PISCATAWAY, N.J.– Camber Pharmaceuticals announces the addition of trientine hydrochloride capsules, USP to its current portfolio.
Trientine hydrochloride capsules, USP are indicated in the treatment of patients with Wilson’s disease who are intolerant of penicillamine.
Click here to read the complete indication and usage for trientine hydrochloride capsules, USP
Trientine hydrochloride capsules, USP are available in 250 mg strength in 100 count bottles.
To find out more about trientine hydrochloride capsules, USP please visit www.camberpharma.com
